Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
160 studies found for:    ovarian,cancer,prevention
Show Display Options
Rank Status Study
1 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
2 Recruiting Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Condition: Ovarian Cancer
Intervention:
3 Completed Prevention of Ovarian Cancer in Women Participating in Mammography
Condition: Epithelial Ovarian Cancer
Intervention: Behavioral: genetic counseling
4 Recruiting Cancer Screening and Prevention Program for High Risk Women
Conditions: Ovarian Cancer;   Breast Cancer
Intervention:
5 Terminated Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Procedure: Seprafilm™
6 Completed
Has Results
Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)
Condition: Ovarian Neoplasms
Intervention: Drug: Caelyx (Pegylated Lyposomal Doxorubicin)
7 Active, not recruiting Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
Condition: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Intervention: Drug: Metformin
8 Unknown  Why do Oral Contraceptives Prevent of Ovarian Cancer?
Conditions: Ovarian Cancer Risk;   Risk-reducing Surgery;   Fallopian Tube Fimbriae;   Ovarian Cortical Inclusion Cysts
Intervention: Drug: OrthoNovum 1/35
9 Terminated
Has Results
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Dietary Supplement: Arm A: Vitamin D3 Group;   Dietary Supplement: Placebo
10 Completed Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques
Conditions: Uterine Fibroids;   Contraception Desired
Interventions: Procedure: Standard PBS;   Procedure: Radical PBS
11 Completed Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
Condition: Breast Cancer
Intervention: Drug: Goserelin
12 Recruiting Cancer Prevention in Women With a BRCA Mutation
Conditions: BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Breast Cancer;   Ovarian Cancer
Intervention: Behavioral: Follow-up Telephone Genetic Counselling
13 Recruiting Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Behavioral: psychoeducation
14 Recruiting The Women Choosing Surgical Prevention (WISP) Trial
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Procedure: Salpingectomy;   Procedure: Oophorectomy;   Behavioral: Questionnaires
15 Withdrawn Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Conditions: Fatigue;   Malignant Ovarian Mixed Epithelial Tumor;   Neuropathy;   Neurotoxicity Syndrome;   Ovarian Brenner Tumor;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Pain;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Dietary Supplement: Acetyl-L-Carnitine Hydrochloride;   Other: Placebo;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
16 Completed Elizabeth Registry for Low Grade Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
17 Unknown  A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Paclitaxel, Carboplatin and Vorinostat
18 Completed Statewide Communication to Reach Diverse Low Income Women
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Behavioral: Intervention Group;   Behavioral: Delayed Intervention Group
19 Completed
Has Results
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
Conditions: Ovarian Neoplasms;   Breast Neoplasms;   Paresthesia
Intervention:
20 Suspended Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Conditions: Malignant Ovarian Mixed Epithelial Tumor;   Nausea and Vomiting;   Ovarian Brenner Tumor;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Stage II Ovarian Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer;   Undifferentiated Ovarian Carcinoma
Interventions: Procedure: Adjuvant Therapy;   Drug: Aprepitant;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Dexamethasone;   Drug: Granisetron Transdermal Patch;   Procedure: Management of Therapy Complications;   Other: Questionnaire Administration

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.